Drug Type Small molecule drug |
Synonyms Anemet, Anzemet, Dolasetron + [7] |
Target |
Mechanism 5-HT3 receptor antagonists(Serotonin 3 (5-HT3) receptor antagonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date |
Regulation- |
Molecular FormulaC20H26N2O7S |
InChIKeyQTFFGPOXNNGTGZ-BHSFMSKKSA-N |
CAS Registry878143-33-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Dolasetron Mesylate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Nausea | CN | 18 Jul 2011 | |
Vomiting | CN | 18 Jul 2011 | |
Nausea and vomiting | CA | 25 Sep 1997 | |
Chemotherapy-induced nausea and vomiting | US | 11 Sep 1997 | |
Postoperative Nausea and Vomiting | US | 11 Sep 1997 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psychotic Disorders | Phase 3 | EU | - |